Weiss Patrick 4
4 · Twist Bioscience Corp · Filed Oct 15, 2021
Insider Transaction Report
Form 4
Weiss Patrick
VP of Operations
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2021-10-13−1,974→ 51,324 totalExercise: $26.66Exp: 2028-11-18→ Common Stock (1,974 underlying) - Exercise/Conversion
Common Stock
2021-10-13$8.82/sh+2,105$18,566→ 51,101 total - Exercise/Conversion
Common Stock
2021-10-13$25.02/sh+827$20,692→ 53,902 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-10-13−827→ 21,513 totalExercise: $25.02Exp: 2029-12-09→ Common Stock (827 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-10-13−2,105→ 0 totalExercise: $8.82Exp: 2027-09-28→ Common Stock (2,105 underlying) - Exercise/Conversion
Common Stock
2021-10-13$26.66/sh+1,974$52,627→ 53,075 total - Sale
Common Stock
2021-10-13$104.00/sh−4,906$510,224→ 48,996 total
Footnotes (4)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020.
- [F2]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F4]25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.